{"artifact":{"id":"rp-ad-bdnf-202604280307","artifact_type":"research_plan","entity_ids":"[\"BDNF\", \"Alzheimer's disease\"]","title":"AD Research Plan: BDNF targeting in Alzheimer's disease","quality_score":0.82,"created_by":"ad_master_plan_synthesizer","provenance_chain":"[]","content_hash":"7282b55244f486d130dcfc975fc114784f60462f33aac5d3d5357b9f3456b157","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-28T03:07:55.427436"},"disease":"Alzheimer's disease","cost_usd":967000.0,"timeline":"18-24 months","prereg_id":"8","assay_spec":"Phase 2 RCT comparing BDNF modulator vs. placebo in N=300 early AD patients, primary endpoint: change from baseline on composite cognitive score at 18 months. Sample size powered at 80% for effect size=0.32, alpha=0.05.","hypothesis":"BDNF-mediated hippocampal synaptic rescue restores CA3-CA1 connectivity and prevents downstream tau-mediated neurodegeneration in AD","power_calc":{"test":"two-sided t-test","alpha":0.05,"power":0.8,"effect_size":0.32},"sample_size":300,"target_gene":"BDNF","kill_criteria":["BDNF upregulation fails to improve hippocampal-cortical connectivity in MCI patients","CA3-CA1 synaptic rescue does not translate to behavioral improvement in AD patients","TrkB agonist shows no disease-modifying effect in 12-month trial"],"_schema_version":1,"primary_endpoint":"Composite cognitive score (ADAS-Cog13 + ADCS-ADL)","upstream_target_id":"ut-ad-bdnf-202604280307","identification_strategy":"RCT + KO"},"created_at":"2026-04-27T20:07:55.427507-07:00","updated_at":"2026-04-27T20:07:55.427507-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"9b33f310-a417-4e11-92d7-cd74e4390670","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"ad_master_plan_synthesizer"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"ut-ad-bdnf-202604280307","link_type":"derives_from","strength":1.0,"evidence":"Research plan tests upstream target ut-ad-bdnf-202604280307"}],"incoming_links":[],"current_artifact_id":"rp-ad-bdnf-202604280307","is_canonical":true,"supersede_chain":["rp-ad-bdnf-202604280307"]}